Announcement reinforces SGS’s position as one of the few European CROs offering end-to-end human ADME programs This ...

Organotics, a brain organoid startup, uses AI and patient-derived brain models to fast-track personalized medicine for autism and reduce psychiatric drug failure.

Funding backs a human-first approach to drug safety and efficacy, reducing reliance on animal testing and accelerating therapies for patients. NEW HAVEN, CT / ACCESS Newswire / December 5, 2025 / ...

Researchers are closing in on a new kind of protection against the deadliest drug in the United States: a vaccine that trains the immune system to trap fentanyl before it reaches the brain. If early ...

A vaccine to protect against fentanyl’s deadly effects is headed for clinical trials in humans. The vaccine, which showed positive results in studies of mice and rats, is designed to block fentanyl ...

Human challenge trials offer a complementary approach. By safely and deliberately exposing healthy adult volunteers to a well characterised virus under controlled conditions, researchers can generate ...

Following successful small-animal trials that confirmed bioequivalence, BioNxt is now taking the final preclinical step to prepare its sublingual Cladribine formulation for human testing. The upcoming ...

A stylized image of Max Barnhart sitting on a chair with his arm on a pillow, receiving an IV infusion. The background is a grid containing a microscope image of malaria parasites flanked on each side ...

Hyderabad-based SCIINV Biosciences has identified a new AI-driven repurposed antibiotic now entering human clinical trials.

What’s been overlooked is that the FDA already has the power to fix this. Without new legislation, pilot programs, or years ...

Jo Varshney, PhD, DVM, discusses how VeriSIM Life’s innovative approach leverages artificial intelligence and multispecies data. Despite decades of advances in drug discovery, nearly 90% of drug ...

FIRST CLINICAL TRIAL OF A NEW CANCER DRUG FOR CATS. AND IT COULD HAVE APPLICATIONS FOR HUMANS. YEAH, IT’S INTERESTING. SCIENTISTS AT UC DAVIS AND UC SAN FRANCISCO HAVE TREATED CATS WITH SQUAMOUS CELL ...